Dai Nippon Printing (DNP) Invests in US Molecular Imprint Venture Concern.Tokyo, Japan, Sept 26, 2005 - (JCNN JCNN Japan Corporate News Network ) - Dai Nippon Printing Dai Nippon Printing (大日本印刷 Dai Nippon Insatsu (DNP DNP n. Deoxyribonucleoprotein; a complex of DNA and protein that usually yields DNA upon cell disruption and isolation. DNP 2,4-dinitrophenol. ) has invested $5 million in Molecular Imprints (MII), an Austin, Texas, venture company that specializes in nano-imprint lithography system development and sales. The equity participation in the US company will allow DNP to focus, as MII's strategic partner, on the development and sales of templates that are used in the MII lithography systems. DNP aims to further improve nano-printing technologies for wider acceptance in the industry by introducing its template products to MII product users. DNP (TSE See Tokyo Stock Exchange. TSE 1. See Tokyo Stock Exchange (TSE). 2. See Toronto Stock Exchange (TSE). : 7912) is projecting template sales of 200 million yen ($1.8 mil) in fiscal 2006. Source: JCN http://www.japancorp.net Copyright [c] 2005 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion